Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 482
Immune Disorders Drugs 201
Drug Discovery 169
Cardiovascular Drugs 159
Infectious Diseases Drugs 138
Biopharmaceuticals 133
Clinical Trials 126
Endocrine and Metabolic Disorders Drugs 110
Central Nervous System Drugs 100
Pharmaceuticals 95
Musculoskeletal Disorders Drugs 94
Leukemia Drugs 84
Hematological Drugs 83
Liver and Kidney Disorders Drugs 81
Lymphoma Drugs 62
Dermatological Drugs 55
Diabetes Drugs 54
Skin Cancer Drugs 51
Brain Cancer Drugs 45
Respiratory Drugs 44
Gastrointestinal Drugs 41
Mental Disorders Drugs 41
Lung Cancer Drugs 39
Pharmaceutical Intermediates 38
Drug Delivery 37
Immunosuppressive Drugs 34
Pharmaceutical Manufacturing 33
Infusions and Injectables 30
Liver Cancer Drugs 28
Bladder Cancer Drugs 25
Analgesics 25
Drugs by Therapeutic Area 24
Antibiotics 23
Kidney Cancer Drugs 22
Colon Cancer Drugs 20
HIV/AIDS Drugs 20
Prostate Cancer Drugs 18
Pancreatic Cancer Drugs 18
Schizophrenia Drugs 18
Urological Disorders Drugs 17
Sexual and Reproductive Health Drugs 15
Ovarian Cancer Drugs 14
Cervical Cancer Drugs 14
Breast Cancer Drugs 13
Cancer Vaccines 13
Thyroid Cancer Drugs 12
Psoriasis Drugs 12
Generic Drugs 10
Biosimilars and Biosuperiors 10
Over the Counter (OTC) Drugs 9
Vaccines 9
Transdermal and Transmucosal Drug Delivery 8
Anti-Obesity Drugs 8
Optical Disorders Drugs 7
Alzheimer's Disease Drugs 7
Uterine Cancer Drugs 6
Company Reports 5
Anxiety Drugs 4
Pharmacoeconomics 3
Cough and Cold Drugs 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



276 reviews

2,463 Results (Page 1 of 124)
- Relevance
  Sort by

Paclitaxel Injection Global Market Report 2024

 Report
February 2024
175 Pages
Global

From

€4967EUR$5,000USD£4,130GBP

Paclitaxel Injection Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
July 2023
95 Pages
Global

From

€3500EUR$3,774USD£3,012GBP

Ophthalmic Drugs Contract Manufacturing Market: Focus on Active Pharmaceutical Ingredients and Finished Dosage Forms (Ophthalmic Drops, Emulsions, Gels, Injections, Lotions, Ointments, Suspensions, and Tablets / Capsules), 2020-2030

 Report
January 2020
473 Pages
Global

From

€4867EUR$4,899USD£4,047GBP

Triamcinolone Ointment Chlorofluorocarbons Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

 Report
January 2022
115 Pages
Global

From

€4719EUR$4,750USD£3,924GBP

Adalimumab, Infliximab and Etanercept Biosimilars Global Market Report 2024

 Report
February 2024
250 Pages
Global

From

€4967EUR$5,000USD£4,130GBP

NEED HELP FINDING THE RIGHT PRODUCT? Eman will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Sunitinib Malate - Global Strategic Business Report

 Report
November 2024
193 Pages
Global

From

€4918EUR$4,950USD£4,089GBP

Ampicillin Trihydrate Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2024
80 Pages
Global

From

€3500EUR$3,774USD£3,012GBP

Live Biotherapeutic Products and Microbiome Contract Manufacturing Market: Focus on Active Pharmaceutical Ingredients and Finished Dosage Forms, 2020-2030

 Report
March 2020
306 Pages
Global

From

€4867EUR$4,899USD£4,047GBP

Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
83 Pages
Global

From

€3477EUR$3,500USD£2,891GBP

Etopophos Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type

 Report
August 2024
84 Pages
Global

From

€3500EUR$3,774USD£3,012GBP

Human Immunodeficiency Virus Therapeutics Market Size, Share & Trends Analysis Report By Drug Type, By Drug Class (Entry & Fusion Inhibitors, Protease Inhibitors, Integrase Inhibitors), By Region, And Segment Forecasts, 2023 - 2030

 Report
October 2023
75 Pages
Global

From

€5911EUR$5,950USD£4,915GBP

Skin Cancer Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

 Report
April 2023
120 Pages
Global

From

€4719EUR$4,750USD£3,924GBP

Human Immunodeficiency Virus Therapeutics Market by Drug Class, End-User, Distribution Channel - Global Forecast 2025-2030

 Report
October 2024
190 Pages
Global

From

€3522EUR$3,545USD£2,928GBP

€3913EUR$3,939USD£3,254GBP

Opdivo (nivolumab; Bristol-Myers Squibb/Ono Pharmaceutical) Drug Overview 2019

 Drug Pipelines
September 2019
118 Pages
Global

€9934EUR$10,000USD£8,260GBP

Hepatitis Therapeutics - Global Strategic Business Report

 Report
November 2024
94 Pages
Global

From

€5563EUR$5,600USD£4,626GBP

Hepatitis C Treatment - Global Strategic Business Report

 Report
November 2024
208 Pages
Global

From

€5414EUR$5,450USD£4,502GBP

Hematologic Malignancies Market Report by Type, Therapy, End User, and Region 2024-2032

 Report
August 2024
136 Pages
Global

From

€3873EUR$3,899USD£3,221GBP

Advanced Renal Cell Carcinoma (RCC) - Market Insight, Epidemiology and Market Forecast - 2034

 Report
June 2024
200 Pages
Global

From

€5529EUR$5,565USD£4,597GBP

€7898EUR$7,950USD£6,567GBP

Renal cell carcinoma - Pipeline Insight, 2024

 Clinical Trials
April 2024
60 Pages
Global

From

€1391EUR$1,400USD£1,156GBP

€1987EUR$2,000USD£1,652GBP

Global Lung Cancer Antibodies Market, Drug Sales & Clinical Trials Insight 2028

 Report
May 2022
510 Pages
Global

From

€2980EUR$3,000USD£2,478GBP

2,463 Results (Page 1 of 124)
- 1
- 2
- 3

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.